These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2686067)

  • 1. [Calcium antagonist treatment of renal hypertension--a new step on the way to optimizing hypotensive therapy].
    Galstian GM
    Ter Arkh; 1989; 61(8):138-43. PubMed ID: 2686067
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antihypertensive treatment in kidney diseases: whom, with what, how intensively?].
    Ritz E; Heidland A; Nowack R; Rambausek M
    Dtsch Med Wochenschr; 1990 Aug; 115(35):1325-8. PubMed ID: 2202580
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
    Narita H; Murata S; Yabana H; Kikkawa K; Sugawara Y; Akimoto Y; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of antihypertensive therapy on renal function in nephrogenic hypertension].
    Figarov IG; Dzhavad-Zade SM
    Urol Nefrol (Mosk); 1998; (3):27-9. PubMed ID: 9644986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can calcium channel blockers preserve renal function better than diuretics during antihypertensive treatment?
    Fukuda M; Kimura G
    Arch Intern Med; 2005 Jun; 165(11):1312; author reply 1312-3. PubMed ID: 15956015
    [No Abstract]   [Full Text] [Related]  

  • 9. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
    Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive drugs in renal failure.
    Albert FW
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S108-12. PubMed ID: 7898089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of hypotensive therapy on kidney function in hypertensive states].
    Shershnev VG; Shcherban' NN; Gorodetskiĭ AL
    Ter Arkh; 1973 Oct; 45(10):85-8. PubMed ID: 4783250
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal effects of antihypertensive agents in parenchymal renal disease and renovascular hypertension.
    Mimran A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S45-50. PubMed ID: 1382165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of felodipine in patients with refractory hypertension and progressive renal disease.
    Herlitz H; Nyberg G; Granérus G; Björck S; Aurell M
    Scand J Urol Nephrol Suppl; 1988; 108():31-4. PubMed ID: 3163828
    [No Abstract]   [Full Text] [Related]  

  • 14. More is less? Optimal combination therapy for adequate blood pressure lowering in hypertension.
    Kjeldsen SE; Hedner T; Narkiewicz K; Oparil S
    Blood Press; 2008; 17(3):132-3. PubMed ID: 18665471
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in conscious, renal-hypertensive dogs.
    Karasawa A; Ikeda J; Yamada K; Kubo K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1695-7. PubMed ID: 3219142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel blockers and nephroprotection.
    Ungar A; Di Serio C; Lambertucci L; Monami M; Masotti G
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):31-9. PubMed ID: 16640171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blockers: do they offer renal protection?
    Reams GP
    J Hum Hypertens; 1993 Jun; 7(3):211-9. PubMed ID: 8345486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial experience with isradipine for the treatment of hypertension in children.
    Strauser LM; Groshong T; Tobias JD
    South Med J; 2000 Mar; 93(3):287-93. PubMed ID: 10728516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of verapamil on cardio- and hemodynamics in rats with various models of hypertension].
    Spasov AA; Gurbanov KG; Seredintseva NV; Paperno AA
    Eksp Klin Farmakol; 1997; 60(3):30-3. PubMed ID: 9324394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasodilators, antihypertensive therapy, and the kidney.
    Hollenberg NK
    Circulation; 1987 Jun; 75(6 Pt 2):V39-42. PubMed ID: 2882875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.